Business Wire

NAMSA First to Receive FDA ASCA Accreditation for Medical Device Biocompatibility Testing

TOLEDO, Ohio--(BUSINESS WIRE)--NAMSA, the world’s only 100% medical device-focused Contract Research Organization (CRO) providing full continuum development solutions, announced today that the U.S.
Business Wire

NAMSA Acquires American Preclinical Services (APS), Becoming the Preeminent CRO Leader in Interventional and Surgical Preclinical Research Solutions

MINNEAPOLIS--(BUSINESS WIRE)--NAMSA ®, the world’s only 100% medical device-focused Contract Research Organization (CRO) providing full continuum development solutions, announced today its acquisition ...
Nasdaq

Endonovo Therapeutics Signs Agreement with NAMSA to Develop Reimbursement Strategy for Endonovo Medical Products

LOS ANGELES, CA, April 25, 2022 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB:ENDV) today announced an agreement with NAMSA – a leading Global Contract Research Organization (CRO) and medical ...
Hosted on MSN

NAMSA acquires Labcorp’s medical device testing assets

NAMSA has acquired select assets of Labcorp’s early development medical device testing business. The business acquisition aligns with Namsa’s strategy to broaden its service capabilities for medtech ...
Investing

NAMSA acquires Labcorp’s early development medical device testing unit

TOLEDO - NAMSA, a medical device testing and regulatory consulting firm, has acquired Labcorp’s (NYSE:LH) Early Development medical device testing business, according to a press release issued ...